Multidrug-resistant TB in Eastern region of the EU: is the shorter regimen an exception or a rule?
THORAX (2017)
Journal
THORAX
Volume 72, Issue 9, Pages 850-852Publisher
BMJ PUBLISHING GROUP
Keywords
Categories
Funding
- European Community [FP7-223681]
- Oskar-Helene-Heim
- Gunther Labes
Ask authors/readers for more resources
Authors
I am an author on this paper
Reviews
Recommended
Factors associated with treatment outcome of MDR/RR-TB patients treated with shorter injectable based regimen in West Java Indonesia
Arto Yuwono Soeroto, Raden Desy Nurhayati, Aga Purwiga, Bony Wiem Lestari, Chica Pratiwi, Prayudi Santoso, Iceu Dimas Kulsum, Hendarsyah Suryadinata, Ferdy Ferdian
PLOS ONE (2022)
High-dose gatifloxacin-based shorter treatment regimens for MDR/RR-TB
Qi Nie, Lixuan Tao, Yingying Li, Nanshan Chen, Hua Chen, Yong Zhou, Yanqiu Wang, Huidong Chen, Qiuping Tang, Xianguang Wang, Chaolin Huang, Chengfeng Yang
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2022)
Safety and Effectiveness of an All-Oral, Bedaquiline-Based, Shorter Treatment Regimen for Rifampicin-Resistant Tuberculosis in High Human Immunodeficiency Virus (HIV) Burden Rural South Africa: A Retrospective Cohort Analysis
Ilse Tack, Asnake Dumicho, Liesbet Ohler, Altynay Shigayeva, Abera Balcha Bulti, Kenneth White, Mduduzi Mbatha, Jennifer Furin, Petros Isaakidis
CLINICAL INFECTIOUS DISEASES (2021)
Multidrug resistant staphylococci isolated from pigs with exudative epidermitis in North eastern Region of India
S. Kalai, P. Roychoudhury, T. K. Dutta, P. K. Subudhi, S. Chakraborty, N. N. Barman, A. Sen
LETTERS IN APPLIED MICROBIOLOGY (2021)
Treatment outcomes and safety in children with rifampicin-resistant TB
E. Lopez-Varela, A. J. Garcia-Prats, J. A. Seddon, H. R. Draper, J. Winckler, L. van der Laan, M. Palmer, W. A. Burger, H. S. Schaaf, A. C. Hesseling
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE (2022)
Multidrug-Resistant Campylobacer jejuni on Swine Processing at a Slaughterhouse in Eastern Spain
Clara Marin, Laura Lorenzo-Rebenaque, Judith Moreno-Moliner, Sandra Sevilla-Navarro, Estefania Montero, Ma Carmen Chinillac, Jaume Jorda, Santiago Vega
ANIMALS (2021)
Accelerating development of new shorter TB treatment regimens in anticipation of a resurgence of multi-drug resistant TB due to the COVID-19 pandemic
Simon Tiberi, Michael J. Vjecha, Adam Zumla, Jessica Galvin, Giovanni Battista Migliori, Alimuddin Zumla
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2021)
Meropenem-vaborbactam restoration of first-line drug efficacy and comparison of meropenem-vaborbactam-moxifloxacin versus BPaL MDR-TB regimen
Sanjay Singh, Tawanda Gumbo, Jan-Willem Alffenaar, Gunavanthi D. Boorgula, Prem Shankar, Tania A. Thomas, Keertan Dheda, Lesibana Malinga, Prithvi Raj, Santosh Aryal, Shashikant Srivastava
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2023)
Population pharmacokinetics of bedaquiline in patients with drug-resistant TB
H. Zhu, L. Xie, Z-Q Liu, B. Wang, M-Q Gao, Y. Lu
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE (2021)
Stress resilience in patients with drug-resistant TB
N. Nur, A. B. Sharif, D. K. Mitra
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE (2023)
Depression, stigma and quality of life in people with drug-susceptible TB and drug-resistant TB in Vietnam
L. Redwood, E. M. H. Mitchell, K. Viney, K. Snow, T. A. Nguyen, L. A. T. Dung, V. N. Nguyen, G. J. Fox
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE (2021)
The Cost-Effectiveness of the BEAT-TB Regimen for Pre-Extensively Drug-Resistant TB
Malaisamy Muniyandi, Paranchi Murugesan Ramesh, William A. Wells, Umesh Alavadi, Suvanand Sahu, Chandrasekaran Padmapriyadarsini
TROPICAL MEDICINE AND INFECTIOUS DISEASE (2023)
Treatment outcomes of multidrug-resistant TB with selective use of new drugs
Y-S. Kwon, J. E. Shin, H. Kang, D. Jeon, J-J. Yim, T. S. Shim
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE (2023)
Effectiveness of Shorter Treatment Regimen in Multidrug-Resistant Tuberculosis Patients in Pakistan: A Multicenter Retrospective Record Review
Abudl Wahid, Nafees Ahmad, Abdul Ghafoor, Abdullah Latif, Fahad Saleem, Shereen Khan, Muhammad Atif, Qaiser Iqbal
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2021)
Indirect Treatment Comparisons of Lenacapavir Plus Optimized Background Regimen Versus Other Treatments for Multidrug-Resistant Human Immunodeficiency Virus
Iro Chatzidaki, Tristan Curteis, Hannah Luedke, Dylan J. Mezzio, Martin S. Rhee, Eve McArthur, Lucy A. Eddowes
VALUE IN HEALTH (2023)
Use of a whole genome sequencing-based approach for Mycobacterium tuberculosis surveillance in Europe in 2017-2019: an ECDC pilot study
Elisa Tagliani, Richard Anthony, Thomas A. Kohl, Albert de Neeling, Vlad Nikolayevskyy, Csaba Kodmon, Florian P. Maurer, Stefan Niemann, Dick van Soolingen, Marieke J. van der Werf, Daniela Maria Cirillo
EUROPEAN RESPIRATORY JOURNAL (2021)
Reporting of interferon-gamma release assay results close to cut-off values
D. B. Folkvardsen, Y. Holicka, C. Kodmon, M. J. van der Were, T. Lillebaek, V. Nikolayevskyy
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE (2021)
The potential clinical utility of measuring severe acute respiratory syndrome coronavirus 2-specific T-cell responses
Delia Goletti, Linda Petrone, Davide Manissero, Antonio Bertoletti, Sonia Rao, Nduku Ndunda, Alessandro Sette, Vladyslav Nikolayevskyy
CLINICAL MICROBIOLOGY AND INFECTION (2021)
Current state of national TB laboratory networks in Europe: achievements and challenges
K. Klaos, Y. Holicka, R. Groenheit, C. Kodmon, M. J. van der Werf, V. Nikolayevskyy
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE (2022)
The diagnostic performance of novel skin-based in-vivo tests for tuberculosis nfection compared with purified protein derivative tuberculin skin tests and blood-based in vitro interferon-γ release assays: a systematic review and meta-analysis
Maria Krutikov, Lena Faust, Vladyslav Nikolayevskyy, Yohhei Hamada, Rishi K. Gupta, Daniela Cirillo, Alberto Matteelli, Alexei Korobitsyn, Claudia M. Denkinger, Molebogeng X. Rangaka
LANCET INFECTIOUS DISEASES (2022)
Utility of the Whole Genome Sequencing based methodologies in routine European tuberculosis reference laboratory network setting
Yen Holicka, Elisa Tagliani, Daniela Maria Cirillo, Vlad Nikolayevskyy
TUBERCULOSIS (2022)
Updating the approaches to define susceptibility and resistance to anti-tuberculosis agents: implications for diagnosis and treatment
Sophia B. Georghiou, Timothy C. Rodwell, Alexei Korobitsyn, Said H. Abbadi, Kanchan Ajbani, Jan-Willem Alffenaar, David Alland, Nataly Alvarez, Sonke Andres, Elisa Ardizzoni, Alexandra Aubry, Rossella Baldan, Marie Ballif, Ivan Barilar, Erik C. Bottger, Soumitesh Chakravorty, Pauline M. Claxton, Daniela M. Cirillo, Inaki Comas, Chris Coulter, Claudia M. Denkinger, Brigitta Derendinger, Edward P. Desmond, Jurriaan E. M. de Steenwinkel, Keertan Dheda, Andreas H. Diacon, David L. Dolinger, Kelly E. Dooley, Matthias Egger, Maha R. Farhat, Lanfranco Fattorini, Iris Finci, Laure Fournier Le Ray, Victoria Furio, Ramona Groenheit, Tawanda Gumbo, Scott K. Heysell, Doris Hillemann, Harald Hoffmann, Po-Ren Hsueh, Yi Hu, Hairong Huang, Alamdar Hussain, Farzana Ismail, Kiyohiko Izumi, Tomasz Jagielski, John L. Johnson, Priti Kambli, Kone Kaniga, G. H. R. Eranga Karunaratne, Meenu Kaushal Sharma, Peter M. Keller, Ellis C. Kelly, Margarita Kholina, Mikashmi Kohli, Katharina Kranzer, Ian F. Laurenson, Jason Limberis, S-Y Grace Lin, Yongge Liu, Alexandre Lopez-Gavin, Anna Lyander, Diana Machado, Elena Martinez, Faisal Masood, Satoshi Mitarai, Nomonde R. Mvelase, Stefan Niemann, Vladyslav Nikolayevskyy, Florian P. Maurer, Matthias Merker, Paolo Miotto, Shaheed Omar, Ralf Otto-Knapp, Moises Palaci, Juan Jose Palacios Gutierrez, Sharon J. Peacock, Charles A. Peloquin, Jennifer Perera, Catherine Pierre-Audigier, Suporn Pholwat, James E. Posey, Therdsak Prammananan, Leen Rigouts, Jaime Robledo, Neesha Rockwood, Camilla Rodrigues, Max Salfinger, Marcos C. Schechter, Marva Seifert, Sarah Sengstake, Thomas Shinnick, Natalia Shubladze, Vitali Sintchenko, Frederick Sirgel, Sulochana Somasundaram, Timothy R. Sterling, Andrea Spitaleri, Elizabeth Streicher, Philip Supply, Erik Svensson, Elisa Tagliani, Sabira Tahseen, Akiko Takaki, Grant Theron, Gabriela Torrea, Armand Van Deun, Annelies Van Rie, Dick van Soolingen, Roger Vargas, Amour Venter, Nicolas Veziris, Cristina Villellas, Miguel Viveiros, Robin Warren, Shu'an Wen, Jim Werngren, Robert J. Wilkinson, Caie Yang, Tingting Zhang, Danila Zimenkov, Nazir Ismail, Thomas Schon, Claudio U. Koser, Soudeh Ehsani, Jakko van Ingen, F. Ferda Yilmaz
EUROPEAN RESPIRATORY JOURNAL (2022)
M. tuberculosis microvariation is common and is associated with transmission: Analysis of three years prospective universal sequencing in England
David Wyllie, Trien Do, Richard Myers, Vlad Nikolayevskyy, Derrick Crook, Tim Peto, Eliza Alexander, Esther Robinson, A. Sarah Walker, Colin Campbell, E. Grace Smith
JOURNAL OF INFECTION (2022)
Accuracy of interferon gamma release assays for the COVID-19 immunity assessment
Francis Stieber, Nadia Allen, Kara Carpenter, Jenny Howard, Riccardo Alagna, Davide Manissero, Vladyslav Nikolayevskyy
JOURNAL OF VIROLOGICAL METHODS (2022)
Urine biomarkers of pulmonary tuberculosis
Elena Khimova, Ximena Gonzalo, Yulia Popova, Platon Eliseev, Maryandyshev Andrey, Vladyslav Nikolayevskyy, Agnieszka Broda, Francis Drobniewski
EXPERT REVIEW OF RESPIRATORY MEDICINE (2022)
Transcontinental spread and evolution of Mycobacterium tuberculosis W148 European/Russian Glade toward extensively drug resistant tuberculosis
Matthias Merker, Jean-Philippe Rasigade, Maxime Barbier, Helen Cox, Silke Feuerriegel, Thomas A. Kohl, Egor Shitikov, Kadri Klaos, Cyril Gaudin, Rudy Antoine, Roland Diel, Sonia Borrell, Sebastien Gagneux, Vladyslav Nikolayevskyy, Soenke Andres, Valeriu Crudu, Philip Supply, Stefan Niemann, Thierry Wirth
NATURE COMMUNICATIONS (2022)
A systematic review of cost-utility analyses of screening methods in latent tuberculosis infection in high-risk populations
James Mahon, Sophie Beale, Hayden Holmes, Mick Arber, Vladyslav Nikolayevskyy, Riccardo Alagna, Davide Manissero, David Dowdy, Giovanni Battista Migliori, Giovanni Sotgiu, Raquel Duarte
BMC PULMONARY MEDICINE (2022)
The diagnostic performance of novel skin-based in-vivo tests for tuberculosis infection compared with purified protein derivative tuberculin skin tests and bloodbased in vitro interferon-γ release assays: a systematic review and meta-analysis (vol 22, pg 250, 2022)
M. Krutikov, L. Faust, V Nikolayevskyy
LANCET INFECTIOUS DISEASES (2022)
The diagnostic performance of novel skin-based in-vivo tests for tuberculosis infection compared with purified protein derivative tuberculin skin tests and blood-based in vitro interferon-γ release assays: a systematic review and meta-analysis (vol 22, pg 250, 2022)
M. Krutikov, L. Faust, V Nikolayevskyy
LANCET INFECTIOUS DISEASES (2022)
Limited Capability for Testing Mycobacterium tuberculosis for Susceptibility to New Drugs
Hamzah Z. Farooq, Daniela M. Cirillo, Doris Hillemann, David Wyllie, Marieke J. van der Werf, Csaba Kodmon, Vlad Nikolayevskyy
EMERGING INFECTIOUS DISEASES (2021)